5

Borax Morarji Ltd(Merged)

506315 BSE
This stock has been delisted or merged and is no longer actively traded.

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

2
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -10.8% over past five years.

Growth Rate

Revenue Growth
12% higher than 3Y
Net Income Growth
15%

Quarterly Results

Particulars Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017
Sales
11.75
14.05
21.07
11.59
9.64
9.62
11
11.51
15.78
13.86
12.34
13.41
13.85
Expenses
13.28
15.27
22.47
13.56
10.59
10.22
11.94
26.08
15.8
13.66
12.52
13.94
14.05
Operating Profit
-1.53
-1.22
-1.4
-1.97
-0.95
-0.6
-0.94
-14.57
-0.02
0.2
-0.18
-0.53
-0.2
OPM %
-13.02%
-8.68%
-6.64%
-17%
-9.85%
-6.24%
-8.55%
-126.59%
-0.13%
1.44%
-1.46%
-3.95%
-1.44%
Other Income
0.07
-0.38
-3.23
0.45
-0.42
0.03
-0.08
28.63
0.03
0.01
0.07
0.14
0.04
Interest
0.92
0.86
0.84
0.81
0.81
0.76
0.78
0.97
0.9
0.89
0.84
0.88
0.8
Depreciation
0.56
0.46
0.52
0.08
0.32
0.34
0.34
0.32
0.22
0.23
0.23
0.25
0.22
PBT
-2.94
-2.92
-5.99
-2.41
-2.5
-1.67
-2.14
12.77
-1.11
-0.91
-1.18
-1.52
-1.18
Tax %
-30.95%
0%
0%
-65.15%
0%
0%
0%
14.88%
-0.9%
0%
0%
0%
0.85%
Net Profit
-2.03
-2.92
-5.99
-0.83
-2.5
-1.66
-2.14
10.87
-1.1
-0.9
-1.18
-1.52
-1.19
EPS in Rs
-4.51
-6.49
-13.31
-1.84
-5.56
-3.69
-4.76
24.16
-2.44
-2
-2.62
-3.38
-2.64
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Jun 2014 15mMar 2015 9mMar 2016TTM
Sales
51.69
60.13
79.87
74.27
69.35
74.01
77.27
61.74
66.21
46.71
41.77
53.46
Expenses
46.67
53.71
70.94
64.99
64.17
67.91
76.59
62.14
74.35
47.82
58.25
54.17
Operating Profit
5.02
6.42
8.93
9.28
5.18
6.1
0.68
-0.4
-8.14
-1.11
-16.48
-0.71
OPM %
9.71%
10.68%
11.18%
12.49%
7.47%
8.24%
0.88%
-0.65%
-12.29%
-2.38%
-39.45%
-1.33%
Other Income
1.46
1
1.15
0.09
3
0.11
0.37
0.14
1.36
-6.65
27.58
0.26
Interest
2.03
1.88
2.23
2.03
2.24
2.12
2.84
2.15
4.39
2.5
3.32
3.41
Depreciation
1.67
1.76
2.02
2.06
2.1
2.01
2.06
2.01
2.79
1.06
1.32
0.93
PBT
2.78
3.78
5.83
5.28
3.84
2.08
-3.85
-4.42
-13.96
-11.32
6.46
-4.79
Tax %
30.94%
35.71%
35.51%
26.33%
32.55%
33.65%
-22.08%
-33.26%
-30.95%
-13.87%
29.41%
Net Profit
1.92
2.43
3.76
3.89
2.59
1.38
-2.99
-2.94
-9.64
-9.74
4.56
-4.79
EPS in Rs
4.27
5.4
8.36
8.64
5.76
3.07
-6.64
-6.53
-21.42
-21.64
10.13
-10.64
Div. Payout %
42.38%
40.92%
42.07%
40.67%
43.63%
49.13%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Jun 2014Mar 2015Mar 2016
Equity Capital
4.52
4.52
4.52
4.52
4.52
4.52
4.52
4.52
4.52
4.52
4.52
Reserves
7.13
8.12
8.74
10.71
11.97
12.55
9.65
6.71
-2.93
-12.89
-9
Borrowings
19.81
19.34
21.49
23.09
26.04
27.36
36.45
30.93
29.76
28.26
33
Other Liabilities
20.19
23.99
24.37
23.2
22.03
19.68
17.84
19.72
29.82
38.51
24.06
Total Liabilities
51.65
55.97
59.12
61.52
64.56
64.11
68.46
61.88
61.17
58.4
52.58
Fixed Assets
13.32
14.1
20.05
21.83
19.57
20.21
20.19
27.86
29.41
28.76
23.37
CWIP
0.24
0.07
0.72
0.42
1.59
2.34
6.58
3.25
1.09
1.4
0.14
Investments
1.99
1.99
0.47
0.48
0.42
0.42
0.42
0.43
0.19
0.19
0.19
Other Assets
36.1
39.81
37.88
38.79
42.98
41.14
41.27
30.34
30.48
28.05
28.88
Total Assets
51.65
55.97
59.12
61.52
64.56
64.11
68.46
61.88
61.17
58.4
52.58
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Jun 2014Mar 2015Mar 2016
Operating
2.38
5.51
9.54
4.84
1
5.04
1.73
15.63
6.17
4.93
-24.96
Investing
-0.39
-2.17
-8.05
-3.22
0.53
-3.36
-6.03
-6.27
-1.32
-0.53
22.71
Financing
-2.46
-3.21
-1.31
-2.28
-1.11
-2.32
4.77
-8.99
-5.53
-4
1.43
Net Cash Flow
-0.47
0.13
0.18
-0.66
0.42
-0.64
0.47
0.37
-0.68
0.4
-0.81
Free Cash Flow
1.52
3.14
0.88
1.29
1.36
1.63
-4.46
9.26
4.29
4.17
-2.4
CFO/OP
69
105
124
72
35
94
331
-3,908
-77
-450
152
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Jun 2014Mar 2015Mar 2016
Debtor Days
72.87
67.01
55.71
39.32
45.84
29.15
64.2
31.63
27.12
66.97
54.96
Inventory Days
236
214
109
205
205
216
133
148
106
74.46
66.52
Days Payable
162
159
104
125
99.99
84.57
74.58
120
117
183
210
Cash Conversion Cycle
147
123
60.3
119
151
161
122
59.23
15.9
-41.47
-88.84
Working Capital Days
118
97.91
65.81
81.58
114
107
105
41.32
-35.94
-143
-2.71
ROCE %
17.81%
24.28%
20.99%
11.65%
9.66%
-2.31%
-4.89%
-27.29%
-15.45%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Borax Morarji Ltd(Merged) insights

56 extracted metrics + investor summaries across FY05–FY17.

Log in — free

Shareholding Pattern

Promot.63.63%DIIs0.24%Public36.13%As ofSep 2017

Documents

Frequently Asked Questions about Borax Morarji Ltd(Merged)

What does Borax Morarji Ltd(Merged) do?
Borax Morarji Limited is engaged in the manufacture of boron-based chemicals and wind power generation.
Where is Borax Morarji Ltd(Merged) (506315) listed?
Borax Morarji Ltd(Merged) trades under code 506315 on the BSE.
Which sector does Borax Morarji Ltd(Merged) belong to?
Borax Morarji Ltd(Merged) is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.

Company Information

Borax Morarji Limited is engaged in the manufacture of boron-based chemicals and wind power generation.

Listed 2006-03-01
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506315.md for Borax Morarji Ltd(Merged): company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More